Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 3 Colitis 3 Carcinoma, Non-Small-Cell Lung 3 Urogenital Neoplasms 2 Solid Carcinoma 2 Lung Neoplasms 2 Diarrhea 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Kidney Neoplasms 1 Gastrointestinal Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Colorectal Neoplasms 1 Cachexia 1 Acute Graft Versus Host Disease 1

Interventions

pembrolizumab 90 Blood Specimen Collection 41 Cyclophosphamide 37 Bevacizumab 36 Nivolumab 35 Standard of Care 32 Carboplatin 31 Surveys and Questionnaires 29 Paclitaxel 27 atezolizumab 25 Exercise 25 Pemetrexed 24 Gemcitabine 23 Cisplatin 23 Fluorouracil 22 Radiotherapy 20 Leucovorin 20 Dexamethasone 20 Docetaxel 19 Oxaliplatin 18 Rituximab 16 Irinotecan 16 Cetuximab 16 dostarlimab 15 Drug Therapy 15 Doxorubicin 15 Ipilimumab 14 Biopsy 14 130-nm albumin-bound paclitaxel 14 fludarabine 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Fecal Microbiota Transplantation × 1 year × Clear all

NCT07533227 2026-04-16

FMT-CACH

Changzhou No.2 People's Hospital

Phase 2 Not yet recruiting

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡